A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
Public ClinicalTrials.gov record NCT02274558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of NBI-98854 for the Treatment of Tardive Dyskinesia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of NBI-98854 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.
Study identification
- NCT ID
- NCT02274558
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Type not available)
- Primary completion
- Sep 2015 (Actual)
- Completion
- Jul 2016 (Actual)
- Last update posted
- Jul 11, 2017
2014 – 2016
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | San Bernardino | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Leesburg | Florida | — | — |
| Not listed | Maitland | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | North Miami | Florida | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Oak Brook | Illinois | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Glen Burnie | Maryland | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Flowood | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Lincoln | Nebraska | — | — |
| Not listed | Amherst | New York | — | — |
| Not listed | Cedarhurst | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Pinehurst | North Carolina | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Shaker Heights | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Conshohocken | Pennsylvania | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Phoenixville | Pennsylvania | — | — |
| Not listed | Scranton | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | DeSoto | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | Petersburg | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02274558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2017 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02274558 live on ClinicalTrials.gov.